Terms: = Skin cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
61 results:
1. Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.
Mahgoub TM; Jordan EJ; Mahdi AF; Oettl V; Huefner S; O'Donovan N; Crown J; Collins DM
Cancer Chemother Pharmacol; 2024 May; 93(5):427-437. PubMed ID: 38226983
[TBL] [Abstract] [Full Text] [Related]
2. Acquired and intrinsic resistance to vemurafenib in BRAF
Zhang P; Kuil LE; Buil LCM; Freriks S; Beijnen JH; van Tellingen O; de Gooijer MC
FEBS Open Bio; 2024 Jan; 14(1):96-111. PubMed ID: 37953496
[TBL] [Abstract] [Full Text] [Related]
3. Putative cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells
Speigl L; Janssen N; Weide B; Sinnberg T; Pawelec G; Shipp C
Front Biosci (Landmark Ed); 2023 Sep; 28(9):193. PubMed ID: 37796710
[TBL] [Abstract] [Full Text] [Related]
4. PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma.
Fontana F; Macchi C; Anselmi M; Rizzuto AS; Ruscica M; Limonta P
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166897. PubMed ID: 37758066
[TBL] [Abstract] [Full Text] [Related]
5. Neuropilin-2 Inhibits Drug Resistance and Progression of Melanoma Involving the MiR-331-3p Regulated Cascade.
Xie Q; Zhang R; Liu D; Yang J; Hu Q; Shan C; Li X
Curr Mol Pharmacol; 2023; 16(7):787-799. PubMed ID: 36545728
[TBL] [Abstract] [Full Text] [Related]
6. Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer.
Yokota H; Sato K; Sakamoto S; Okuda Y; Fukuda N; Asano M; Takeda M; Nakayama K; Miura M
Invest New Drugs; 2022 Dec; 40(6):1254-1262. PubMed ID: 36149549
[TBL] [Abstract] [Full Text] [Related]
7. p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells.
Pietrobono S; De Paolo R; Mangiameli D; Marranci A; Battisti I; Franchin C; Arrigoni G; Melisi D; Poliseno L; Stecca B
J Biol Chem; 2022 Sep; 298(9):102353. PubMed ID: 35944584
[TBL] [Abstract] [Full Text] [Related]
8. CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma.
Berico P; Cigrang M; Davidson G; Braun C; Sandoz J; Legras S; Vokshi BH; Slovic N; Peyresaubes F; Gene Robles CM; Egly JM; Compe E; Davidson I; Coin F
EMBO Rep; 2021 Sep; 22(9):e51683. PubMed ID: 34296805
[TBL] [Abstract] [Full Text] [Related]
9. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
[TBL] [Abstract] [Full Text] [Related]
10. Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris.
Jarocka-Karpowicz I; Biernacki M; Wroński A; Gęgotek A; Skrzydlewska E
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32121131
[TBL] [Abstract] [Full Text] [Related]
11. Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma.
Goey AK; With M; Agema BC; Hoop EO; Singh RK; van der Veldt AA; Mathijssen RH; van Schaik RH; Bins S
Pharmacogenomics; 2019 Dec; 20(18):1283-1290. PubMed ID: 31829834
[No Abstract] [Full Text] [Related]
12. Metabolome Analysis Reveals Dermal Histamine Accumulation in Murine Dermatitis Provoked by Genetic Deletion of P-Glycoprotein and Breast cancer Resistance Protein.
Hashimoto N; Nakamichi N; Nanmo H; Kimura KI; Masuo Y; Sakai Y; Schinkel AH; Sato S; Soga T; Kato Y
Pharm Res; 2019 Sep; 36(11):158. PubMed ID: 31512001
[TBL] [Abstract] [Full Text] [Related]
13. Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.
Reddick SJ; Campagne O; Huang J; Onar-Thomas A; Broniscer A; Gajjar A; Stewart CF
Cancer Chemother Pharmacol; 2019 Oct; 84(4):829-838. PubMed ID: 31392390
[TBL] [Abstract] [Full Text] [Related]
14. Effects of pharmacokinetics-related genetic polymorphisms on the side effect profile of afatinib in patients with non-small cell lung cancer.
Hayashi H; Iihara H; Hirose C; Fukuda Y; Kitahora M; Kaito D; Yanase K; Endo J; Ohno Y; Suzuki A; Sugiyama T
Lung Cancer; 2019 Aug; 134():1-6. PubMed ID: 31319966
[TBL] [Abstract] [Full Text] [Related]
15. Influx and Efflux Transporters Contribute to the Increased Dermal Exposure to Active Metabolite of Regorafenib After Repeated Oral Administration in Mice.
Al-Shammari AH; Masuo Y; Fujita KI; Yoshikawa Y; Nakamichi N; Kubota Y; Sasaki Y; Kato Y
J Pharm Sci; 2019 Jun; 108(6):2173-2179. PubMed ID: 30685396
[TBL] [Abstract] [Full Text] [Related]
16. Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases.
Gampa G; Kim M; Mohammad AS; Parrish KE; Mladek AC; Sarkaria JN; Elmquist WF
J Pharmacol Exp Ther; 2019 Mar; 368(3):446-461. PubMed ID: 30622172
[TBL] [Abstract] [Full Text] [Related]
17. A Proof-of-Concept Study to Inhibit abcg2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier.
Bauer M; Karch R; Wulkersdorfer B; Philippe C; Nics L; Klebermass EM; Weber M; Poschner S; Haslacher H; Jäger W; Tournier N; Wadsak W; Hacker M; Zeitlinger M; Langer O
J Nucl Med; 2019 Apr; 60(4):486-491. PubMed ID: 30237210
[TBL] [Abstract] [Full Text] [Related]
18. In silico analysis of nsSNPs in ABCB1 gene affecting breast cancer associated protein P-glycoprotein (P-gp).
Chakraborty R; Gupta H; Rahman R; Hasija Y
Comput Biol Chem; 2018 Dec; 77():430-441. PubMed ID: 30181081
[TBL] [Abstract] [Full Text] [Related]
19. Cytotoxicity of 18 Cameroonian medicinal plants against drug sensitive and multi-factorial drug resistant cancer cells.
Mbaveng AT; Manekeng HT; Nguenang GS; Dzotam JK; Kuete V; Efferth T
J Ethnopharmacol; 2018 Aug; 222():21-33. PubMed ID: 29709646
[TBL] [Abstract] [Full Text] [Related]
20. Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.
Marzagalli M; Moretti RM; Messi E; Marelli MM; Fontana F; Anastasia A; Bani MR; Beretta G; Limonta P
Sci Rep; 2018 Jan; 8(1):587. PubMed ID: 29330434
[TBL] [Abstract] [Full Text] [Related]
[Next]